Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -37.50% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 9.30% vs 39.44% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 42.86% vs 74.07% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 4.00% vs 31.58% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Transgene Biotek With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -37.50% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -16.67% vs 20.00% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 9.30% vs 39.44% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -457.14% vs 46.15% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 42.86% vs 74.07% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs 33.33% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 4.00% vs 31.58% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 1,200.00% vs -33.33% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






